Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.71 USD | -2.29% | -5.00% | +202.65% |
09/05 | Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M | MT |
09/05 | Transcript : Nektar Therapeutics, Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+202.65% | 321M | |
+39.49% | 723B | |
+34.46% | 595B | |
-2.93% | 369B | |
+19.84% | 332B | |
+1.94% | 282B | |
+17.02% | 244B | |
+9.52% | 208B | |
-4.87% | 205B | |
+1.04% | 168B |
- Stock Market
- Equities
- NKTR Stock
- News Nektar Therapeutics
- Insider Sell: Nektar Therapeutics